Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9125)
All Articles published online
|
Publishing Process of This Article
|
Apr 7, 2017 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wu JH, Guo JP, Shi J, Wang H, Li LL, Guo B, Liu DX, Cao Q, Yuan ZY. CMA down-regulates p53 expression through degradation of HMGB1 protein to inhibit irradiation-triggered apoptosis in hepatocellular carcinoma. World J Gastroenterol 2017; 23(13): 2308-2317 [PMID: 28428710 DOI: 10.3748/wjg.v23.i13.2308] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v23/i13/2308.htm |
| Number | Citing Articles |
| 1 |
Kumsal Tekirdag, Ana Maria Cuervo. Chaperone-mediated autophagy and endosomal microautophagy: Jointed by a chaperone. Journal of Biological Chemistry 2018; 293(15): 5414 doi: 10.1074/jbc.R117.818237
|
| 2 |
Wenming Li, Juan Dou, Jing Yang, Haidong Xu, Hua She. Targeting Chaperone-Mediated Autophagy for Disease Therapy. Current Pharmacology Reports 2018; 4(3): 261 doi: 10.1007/s40495-018-0138-1
|
| 3 |
Amelina Albornoz, Alvaro Sequeida, Christian Rodríguez, Mauricio Budini. Autophagy in Health and Disease. 2022; : 399 doi: 10.1016/B978-0-12-822003-0.00004-8
|
| 4 |
Jen Chin Wang, Guanfang Shi, Chi Chen, Ching Wong, Vladimir Gotlieb, Gardith Joseph, Kiron V Nair, Lakshmi Boyapati, Enayati Ladan, James T. Symanowski, Lishi Sun, Daniela Caccamo. TLR2 Derangements Likely Play a Significant Role in the Inflammatory Response and Thrombosis in Patients with Ph(−) Classical Myeloproliferative Neoplasm. Mediators of Inflammation 2024; 2024(1) doi: 10.1155/2024/1827127
|
| 5 |
Esperanza Arias, Ana Maria Cuervo. Pros and Cons of Chaperone-Mediated Autophagy in Cancer Biology. Trends in Endocrinology & Metabolism 2020; 31(1): 53 doi: 10.1016/j.tem.2019.09.007
|
| 6 |
Yuanyuan Zhao, Jun Yi, Leilei Tao, Guichun Huang, Xiaoyuan Chu, Haizhu Song, Longbang Chen. Wnt signaling induces radioresistance through upregulating HMGB1 in esophageal squamous cell carcinoma. Cell Death & Disease 2018; 9(4) doi: 10.1038/s41419-018-0466-4
|
| 7 |
Raquel Gómez-Sintes, Esperanza Arias. Chaperone-mediated autophagy and disease: Implications for cancer and neurodegeneration. Molecular Aspects of Medicine 2021; 82: 101025 doi: 10.1016/j.mam.2021.101025
|
| 8 |
Yong Shi, Erik Norberg, Helin Vakifahmetoglu-Norberg. Mutant p53 as a Regulator and Target of Autophagy. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.607149
|
| 9 |
Saliha Chaudhry, Stefani N. Thomas, Glenn E. Simmons Jr.. Targeting lipid metabolism in the treatment of ovarian cancer. Oncotarget 2022; 13(1): 768 doi: 10.18632/oncotarget.28241
|
| 10 |
Shuangshuang Le, Xin Fu, Maogui Pang, Yao Zhou, Guoqing Yin, Jie Zhang, Daiming Fan. The Antioxidative Role of Chaperone-Mediated Autophagy as a Downstream Regulator of Oxidative Stress in Human Diseases. Technology in Cancer Research & Treatment 2022; 21 doi: 10.1177/15330338221114178
|
| 11 |
Wenming Li, Tiejian Nie, Haidong Xu, Jing Yang, Qian Yang, Zixu Mao. Chaperone-mediated autophagy: Advances from bench to bedside. Neurobiology of Disease 2019; 122: 41 doi: 10.1016/j.nbd.2018.05.010
|
| 12 |
Iván E. Alfaro, Amelina Albornoz, Alfredo Molina, José Moreno, Karina Cordero, Alfredo Criollo, Mauricio Budini. Chaperone Mediated Autophagy in the Crosstalk of Neurodegenerative Diseases and Metabolic Disorders. Frontiers in Endocrinology 2019; 9 doi: 10.3389/fendo.2018.00778
|
| 13 |
Jing Liu, Lijuan Wang, Hua He, Yueying Liu, Yiqun Jiang, Jinfeng Yang. The Complex Role of Chaperone-Mediated Autophagy in Cancer Diseases. Biomedicines 2023; 11(7): 2050 doi: 10.3390/biomedicines11072050
|
| 14 |
Ana Beatriz da Silva Teixeira, Maria Carolina Clares Ramalho, Izadora de Souza, Izabela Amélia Marques de Andrade, Isabeli Yumi Araújo Osawa, Camila Banca Guedes, Beatriz Silva de Oliveira, Cláudio Henrique Dahne de Souza Filho, Tainá Lins da Silva, Natália Cestari Moreno, Marcela Teatin Latancia, Clarissa Ribeiro Reily Rocha. The role of chaperone-mediated autophagy in drug resistance. Genetics and Molecular Biology 2024; 47(suppl 1) doi: 10.1590/1678-4685-gmb-2023-0317
|
| 15 |
Akihiro Ichikawa, Yu Fujita, Yusuke Hosaka, Tsukasa Kadota, Akihiko Ito, Shigehiro Yagishita, Naoaki Watanabe, Shota Fujimoto, Hironori Kawamoto, Nayuta Saito, Masahiro Yoshida, Mitsuo Hashimoto, Shunsuke Minagawa, Hiromichi Hara, Noriko Motoi, Yusuke Yamamoto, Takahiro Ochiya, Jun Araya, Kazuyoshi Kuwano. Chaperone‐mediated autophagy receptor modulates tumor growth and chemoresistance in non–small cell lung cancer. Cancer Science 2020; 111(11): 4154 doi: 10.1111/cas.14629
|
| 16 |
Susmita Kaushik, Ana Maria Cuervo. The coming of age of chaperone-mediated autophagy. Nature Reviews Molecular Cell Biology 2018; 19(6): 365 doi: 10.1038/s41580-018-0001-6
|
| 17 |
Ruhua Wang, Yunong Fu, Menglin Yao, Xiaomeng Cui, Yan Zhao, Xinlan Lu, Yarui Li, Yiguang Lin, Shuixiang He. The HN1/HMGB1 axis promotes the proliferation and metastasis of hepatocellular carcinoma and attenuates the chemosensitivity to oxaliplatin. The FEBS Journal 2022; 289(20): 6400 doi: 10.1111/febs.16531
|
| 18 |
Shasha Zhang, Tingting Liu, Mengdi Zhang, Qi Chen, Min Su, Tuya Bai, Yuxia Hu, Jun Li, Fuhou Chang, Weizhong Huangfu. Study on molecular mechanism of benzo (ɑ) pyrene on CMA by HSP90ɑ and HIF-1ɑ. Toxicology in Vitro 2022; 83: 105372 doi: 10.1016/j.tiv.2022.105372
|
| 19 |
Lin Lu, Donghui Zhang, Yu Xu, Guang Bai, Yong Lv, Jian Liang. miR-505 enhances doxorubicin-induced cytotoxicity in hepatocellular carcinoma through repressing the Akt pathway by directly targeting HMGB1. Biomedicine & Pharmacotherapy 2018; 104: 613 doi: 10.1016/j.biopha.2018.05.087
|
| 20 |
SUSHMA S MURTHY, BALA NARSAIAH T. BIOINFORMATICS APPROACH ON ACTION AND MECHANISM OF BROMELAIN IN HEPATOCELLULAR CARCINOMA. Asian Journal of Pharmaceutical and Clinical Research 2021; : 122 doi: 10.22159/ajpcr.2021.v14i9.42661
|
| 21 |
Yuhan Yang, Liting Xiong, Mengyuan Li, Ping Jiang, Junjie Wang, Chunxiao Li. Advances in radiotherapy and immunity in hepatocellular carcinoma. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04386-y
|
| 22 |
Yusuke Hosaka, Jun Araya, Yu Fujita, Kazuyoshi Kuwano. Role of chaperone-mediated autophagy in the pathophysiology including pulmonary disorders. Inflammation and Regeneration 2021; 41(1) doi: 10.1186/s41232-021-00180-9
|
| 23 |
Dian‑Xing Liu, Peng‑Peng Li, Jia‑Pei Guo, Lei‑Lei Li, Bin Guo, Hong‑Bin Jiao, Jing‑Hua Wu, Jun‑Mao Chen. Exosomes derived from HBV‑associated liver cancer promote chemoresistance by upregulating chaperone‑mediated autophagy. Oncology Letters 2018; doi: 10.3892/ol.2018.9584
|
| 24 |
Zhaozhong Liao, Bin Wang, Wenjing Liu, Qian Xu, Lin Hou, Jinlian Song, Qingming Guo, Ning Li. Dysfunction of chaperone-mediated autophagy in human diseases. Molecular and Cellular Biochemistry 2021; 476(3): 1439 doi: 10.1007/s11010-020-04006-z
|